Mergers & Acquisitions
Teva will pay over $45 billion for the botox maker unit, report the "Wall Street Journal."
Hi, what are you looking for?
Jewish Business News
All posts tagged "Teva Pharmaceutical Industries"
Business
Dutch Stichting Foundation notified Mylan that it has exercised its call option to acquire 488, 388, 431 Mylan preferred shares pursuant to the...
Business
The groups told the US FTC: Increased consolidation has already led to higher prices and to generic drug shortages.
Business
Last week Teva CEO, Erez Vigodman said, “If the Mylan Pharmaceuticals shareholders support the acquisition of Perrigo, Teva will abandon its bid for Mylan.”
Business
Erez Vigodman: Size isn't everything; it's important to be better.
Business
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has completed first step to buy its rival Mylan N.V. (Nasdaq: MYL). The Israeli giant announced...
Business
Teva says it will seek ‘further appellate review’
Business
Teva is now close to the 4.6% stake in Mylan that will give it standing in the Netherlands courts.
Business
Mylan has confirmed it will dual list on the TASE and Nasdaq if it acquires Perrigo
Business
Abbott Laboratories (NYSE: ABT), said it would back the generic pharmaceutical company Mylan’s (MYL) $34 billion bid acquisition of Perrigo Co Plc (PRGO.N). Abbott...